Huiming Peng Selected Research

6- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxaline

1/2022

Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huiming Peng Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 01/2017
3	Pain (Aches) 01/2021 - 01/2020
2	Tuberculosis (Tuberculoses) 01/2022 - 01/2016
2	Infections 11/2020 - 01/2016
2	Multiple Myeloma 07/2014 - 03/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Venous Thromboembolism 01/2020
1	Inflammation (Inflammations) 01/2020
1	Osteoarthritis 01/2020
1	Postoperative Hemorrhage 11/2019
1	Hemorrhage 11/2019
1	Nausea 11/2019
1	Postoperative Pain 11/2019
1	Vomiting 11/2019
1	Hemophilia A (Haemophilia) 01/2019
1	Contracture 01/2019
1	Intraoperative Complications 06/2018
1	Carcinoma (Carcinomatosis) 01/2017
1	Arthritis (Polyarthritis) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 02/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Hypoxia (Hypoxemia) 08/2015
1	Edema (Dropsy) 06/2015
1	Bacteremia 06/2015
1	Sepsis (Septicemia) 06/2015
1	Pulmonary Edema 06/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2012

Drug/Important Bio-Agent (IBA)

3	CeramidesIBA 11/2020 - 06/2015
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2020 - 06/2015
3	AcidsIBA 11/2020 - 06/2015
2	AntigensIBA 01/2022 - 01/2017
2	TetraspaninsIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2015
2	Superoxides (Superoxide)IBA 01/2016 - 06/2015
2	p38 Mitogen-Activated Protein KinasesIBA 07/2014 - 04/2012
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	VaccinesIBA 01/2022
1	6- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxalineIBA 01/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	InterferonsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	NADP (NADPH)IBA 11/2020
1	SphingolipidsIBA 11/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2020
1	Cathepsin DIBA 11/2020
1	Sufentanil (Sufenta)FDA LinkGeneric 10/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	parecoxibIBA 01/2020
1	Tranexamic Acid (AMCA)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Interleukin-2 (IL2)IBA 02/2016
1	AndrogensIBA 02/2016
1	Tight Junction ProteinsIBA 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2015
1	Amitriptyline (Elavil)FDA LinkGeneric 06/2015
1	bcl-X ProteinIBA 04/2012
1	Pharmaceutical PreparationsIBA 03/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011

Therapy/Procedure

3	Immunotherapy 01/2022 - 02/2016
3	Therapeutics 01/2022 - 02/2016
3	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2020 - 01/2017
1	Analgesia 10/2020
1	Blood Transfusion (Blood Transfusions) 11/2019
1	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2019
1	Ilizarov Technique 01/2019
1	Operative Time 06/2018
1	Knee Prosthesis 01/2017